Stock Earnings

Question 1

What are AnaptysBio Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), AnaptysBio Inc has a total asset of $483, Net loss of $-145

Question 2

What are the key financial ratios for ANAB?

Accepted Answer

AnaptysBio Inc's Current ratio is 1.17, has a Net margin is -159.34, sales per share of $3.2.

Question 3

How is AnaptysBio Inc's revenue broken down by segment or geography?

Accepted Answer

AnaptysBio Inc largest revenue segment is GSK - Royalty - Jemperli, at a revenue of 47,381,000 in the most earnings release.For geography, United States and Australia is the primary market for AnaptysBio Inc, at a revenue of 91,280,000.

Question 4

Is AnaptysBio Inc profitable?

Accepted Answer

no, according to the latest financial statements, AnaptysBio Inc has a net loss of $-145

Question 5

Does AnaptysBio Inc have any liabilities?

Accepted Answer

yes, AnaptysBio Inc has liability of 412

Question 6

How many outstanding shares for AnaptysBio Inc?

Accepted Answer

AnaptysBio Inc has a total outstanding shares of 30.47

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	169	91	17	10	63	75
Revenue Growth (YoY)	196%	434.99%	70%	-84%	-16%	838%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	45	42	41	36	21	18
Research & Development	153	163	132	88	98	80
Operating Expenses	198	206	174	125	119	98
Other Non Operating Income (Expenses)	-72	-50	-18	-21	-1	0
Pretax Income	-84	-145	-163	-128	-57	-19
Income Tax Expense	0	0	0	0	0	0
Net Income	-84	-145	-163	-128	-57	-19
Net Income Growth	-49%	-11%	27%	125%	200%	-80%
Shares Outstanding (Diluted)	29.01	28.38	26.92	28.17	27.43	27.3
Shares Change (YoY)	0%	5%	-4%	3%	0%	1%
EPS (Diluted)	-2.91	-5.11	-6.07	-4.57	-2.11	-0.73
EPS Growth	-49%	-16%	33%	117%	189%	-80%
Free Cash Flow	-145	-135	-121	-73	-47	-14
Free Cash Flow Per Share	-4.99	-4.75	-4.49	-2.59	-1.71	-0.51
Gross Margin	--	--	--	--	--	--
Operating Margin	-16.56%	-125.27%	-923.52%	-1,150%	-88.88%	-30.66%
Profit Margin	-49.7%	-159.34%	-958.82%	-1,280%	-90.47%	-25.33%
Free Cash Flow Margin	-85.79%	-148.35%	-711.76%	-730%	-74.6%	-18.66%
EBITDA	-28	-114	-157	-115	-56	-23
EBITDA Margin	-16.56%	-125.27%	-923.52%	-1,150%	-88.88%	-30.66%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-28	-114	-157	-115	-56	-23
EBIT Margin	-16.56%	-125.27%	-923.52%	-1,150%	-88.88%	-30.66%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

AnaptysBio Inc (ANAB) Price

ANAB Stock Price Chart

ANAB Income

Follow-Up Questions